Does the future of pharma lie beyond drugs - update
This article was originally published in Scrip
Executive Summary
In a week when swine influenza made Tamiflu (oseltamivir) and Relenza (zanamivir) household names, a report was published urging the pharmaceutical industry to look forward. While big pharma handled the concerns of reporters across the globe, PricewaterhouseCoopers predicted the death of the industry's traditional business model beyond 2020.